In short
The latest COPD guideline defines COPD by persistent airflow limitation (post-bronchodilator FEV1/FVC <0.70), stresses smoking cessation and inhaler therapy (bronchodilators, ICS/LABA), exacerbation management with antibiotics/steroids, and long-term oxygen when indicated.
What this guide covers: What is COPD? · Diagnosis · Stable-phase treatment · Managing exacerbations · For patients
What is COPD?
Chronic obstructive pulmonary disease is a preventable, treatable condition of persistent airflow limitation, usually from smoking or air-pollutant exposure, causing cough, sputum, and progressively limiting breathlessness. It is a leading global cause of death.
Diagnosis
Spirometry is the gold standard: post-bronchodilator FEV1/FVC <0.70 confirms persistent airflow limitation. Severity is graded by FEV1% predicted. Imaging and lab tests support staging and exclude mimics (asthma, heart failure, lung cancer).
Stable-phase treatment
Smoking cessation is the single most effective step. Inhalers—long-acting bronchodilators (LAMA/LABA), with inhaled steroids added for frequent exacerbators—relieve symptoms. Pulmonary rehabilitation (breathing exercises, exercise) and, for chronic hypoxia, long-term oxygen (≥15 h/day) improve outcomes.
Managing exacerbations
Worsening breathlessness, sputum, and fever signal an exacerbation. Treatment adds short-acting bronchodilators, oral/IV steroids, and antibiotics when purulent sputum is present; oxygen targets 88–92%. Severe cases need non-invasive ventilation.
For patients
If you smoke and get breathless on exertion, ask for a spirometry test. Using inhalers correctly and staying active make the biggest day-to-day difference.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.





